Wolverine Trading
ARNA

Wolverine Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Wolverine Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,083
Closed -$756K – 5701
2020
Q3 		$762K Buy
10,083
+4,823
+92% +$322K ﹤0.01% 2342
2020
Q2 		$330K Buy
+5,260
New +$289K ﹤0.01% 3216
2020
Q1 		– Sell
-5,140
Closed -$236K – 5569
2019
Q4 		$233K Sell
5,140
-2,288
-31% -$108K ﹤0.01% 3877
2019
Q3 		$339K Buy
+7,428
New +$418K ﹤0.01% 3038
2019
Q2 		– Sell
-5,773
Closed -$298K – 5396
2019
Q1 		$259K Buy
+5,773
New +$265K ﹤0.01% 3536
2018
Q4 		– Sell
-8,620
Closed -$338K – 5658
2018
Q3 		$397K Sell
8,620
-35,653
-81% -$1.45M ﹤0.01% 3399
2018
Q2 		$1.75M Hold
44,273
– – ﹤0.01% 1713
2018
Q1 		$1.75M Buy
+44,273
New +$1.72M ﹤0.01% 1713
2017
Q4 		– Sell
-8,842
Closed -$225K – 5727
2017
Q3 		$225K Buy
+8,842
New +$203K ﹤0.01% 3659

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's ARNA Position: Q4 2020 in Review

Wolverine Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 10,083 shares — an estimated $756K sold.

Wolverine Trading first reported a position in ARNA in Q3 2017 and held it in 9 quarters. The position peaked at $1.75M in Q2 2018. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Wolverine Trading reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,083 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $756K.
  • Wolverine Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 9 quarters.
  • Wolverine Trading's Arena Pharmaceuticals Inc position peaked at $1.75M in Q2 2018.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.